HR 3453
108th Congress
House
Health
Abortion
Administrative procedure
Commerce
Congress
Congressional investigations
Congressional reporting requirements
Congressional veto
Department of Health and Human Services
Drug approvals
Drugs
Food and Drug Administration (FDA)
Government Operations and Politics
Government publicity
Labeling
Law
RU-486 Suspension and Review Act of 2003
Introduced: November 6, 2003
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 14, 2003
Referred to the Subcommittee on Health.
Nov 6, 2003
Referred to the House Committee on Energy and Commerce.
Nov 6, 2003
Introduced in House
Plain-English summary
RU-486 Suspension and Review Act of 2003 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been suspended.
Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the contingent reinstatement of such drug if the report determines the approval to have been in accordance with the Federal Food, Drug, and Cosmetic Act.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2